Active Ingredient: ALBUTEROL SULFATE; BUDESONIDE
Proprietary Name: AIRSUPRA
Dosage Form; Route of Administration: AEROSOL, METERED; INHALATION
Strength: EQ 0.09MG BASE/INH;0.08MG/INH
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N214070
Product Number: 001
Approval Date: Jan 10, 2023
Applicant Holder Full Name: ASTRAZENECA PHARMACEUTICALS LP
Marketing Status:
Prescription
Patent and Exclusivity Information
